Impact Factor
3.55
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
4.03
260 total citations
h5-index
26
h5 depth signal
Cited share
81.8%
54 of 66
Total citations
260
Citation footprint
Metric signal
5.09
External metric anchor
Self-citation
0.4%
1 self-citations
Citations Trend
Citing Geographic Demographics
United States
215
China
80
India
53
Brazil
44
Australia
32
Citing Fields of Research
Bacteriology
239
Immunology
124
Antibiotic & Antibacterial Agents
101
Sexually Transmitted Diseases
87
Virology
69
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,028
Articles tracked across the journal lifetime
Indexed publication set
66
54 cited publications
Last 12 months
0
0.0 publications/month
Open access share
0.0%
0 OA publications in the last year
Leading citing country
United States
215 citing publications
Leading citing field
Bacteriology
239 citing publications
Latest tracked publication
24 September 2025
10 recent records available
Coverage & Indexing History
v67n1, Feb. 2013-
v67n1, Feb. 2013-
Active Coverage
Research Focus & Classification
Indexed Subjects
Sexually Transmitted Diseases
Bacteriology
Immunology
HIV
Digestive Disorders
Parasitology
Lipids
Issuing & Sponsoring Bodies
Contributor
Federation of European Microbiological Societies
Broad Categories
Communicable Diseases
Microbiology
Sexually Transmitted Diseases
Bacteriology
Tropical Diseases
Fungal Pathogenesis
Mycobacterial Diseases
Virology
MeSH Descriptors
Disease
Microbiological Phenomena
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1093/femspd/ftaf011
Open DOI
Primary human nasal, nasopharyngeal, and bronchial epithelia show distinct immune responses to various pathogens
The respiratory epithelium serves as initial defense against airborne pathogens through its barrier function and induction of immune responses. To study epithelial-pathogen interactions we used primary epithelial models that closely rese...
02
DOI 10.1093/femspd/ftaf014
Open DOI
Eugenol nanoparticle as a therapeutic agent against Pseudomonas infection in mice
We reported earlier about development of nano-formulation of an essential oil “eugenol” through its entrapment within animal protein “gelatin,” using a simple ultrasonication technique, followed by purification via ultracentrifugation. T...
03
DOI 10.1093/femspd/ftaf013
Open DOI
Akkermansia muciniphila attenuates sepsis-induced immunosuppression by shaping endotoxin-tolerant macrophage phenotypes
Sepsis is a life-threatening condition characterized by immunosuppression, largely mediated by endotoxin tolerance. Akkermansia muciniphila (AKK), a gut probiotic, has been shown to modulate immune responses. In this study, 16S rRNA sequ...
04
DOI 10.1093/femspd/ftaf012
Open DOI
Inc/GFP chimera protein-based interactomics reveals host cellular interactions of Cps0558, a novel Chlamydia psittaci inclusion protein
The obligate intracellular Gram-negative bacterium Chlamydia psittaci, a zoonotic pathogen transmissible between birds and humans, has played a pioneering role in research on its membrane-bound replicative niche termed the inclusion. Inc...
05
06
07
08
09
DOI 10.1093/femspd/ftaf006
Open DOI
Characterization of BK polyomavirus-associated nephropathy (BKPyVAN) in kidney transplant recipients using transcriptomic analysis: a comprehensive scoping review
BK polyomavirus (BKPyV) infection reactivates with immunosuppressive therapies and can lead to the development of BKPyV-associated nephropathy (BKPyVAN) in kidney transplant recipients. This scoping review assesses the use of transcripto...
10
DOI 10.1093/femspd/ftaf005
Open DOI
Inflammatory phenotypes and clinical outcomes amongst patients with presumed and confirmed Pneumocystis jirovecii pneumonia without underlying human immunodeficiency virus infection
Pneumocystis jirovecii pneumonia (PJP) has significant mortality, especially in immunocompromised hosts without underlying human immunodeficiency virus infection (HIV). Inflammatory phenotypes may influence clinical outcomes. This study ...
Bibliographical & Catalog Notes
Published on behalf of the Federation of European Microbiological Societies.